Biodesix, Inc. (BDSX) — Stock Score Summary

Biodesix, Inc. (BDSX) has a MoatMap StockRank of 58/100 based on Quality (31/100), Value (38/100), and Momentum (74/100) factor scores. The current signal is HOLD. Biodesix is a diagnostics company focused on lung cancer. It lacks scale, is unprofitable, and does not align with any of our high-conviction macro themes.

Biodesix, Inc. is a diagnostics company that develops and commercializes rapid, blood-based tests for lung cancer and other pulmonary diseases. The company's competitive advantage lies in its proprietary multi-omics platform and artificial intelligence, which deliver actionable clinical results within 72 hours, bypassing the need for invasive tissue biopsies. Biodesix operates as a high-growth niche player in the precision oncology space, supported by expanding Medicare coverage and clinical adoption.

Key Financial Metrics

Price$15.36
Market Cap$166M
P/E (Forward)-75.00
Price/Book18.25
Return on Equity-316.5%
Return on Invested Capital-39.3%
Debt/Equity805.61
Gross Margin81.7%
Operating Margin-25.8%
Revenue Growth42.3%
Free Cash Flow$-14M

Biodesix, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Biodesix, Inc.’s (BDSX) StockRank?
MoatMap’s StockRank for Biodesix, Inc. (BDSX) is 58/100, with a Hold signal. It is a composite of Quality (31), Value (38), and Momentum (74) factor ranks across MoatMap’s 19,000+ stock universe.
Does Biodesix, Inc. have an economic moat?
Biodesix, Inc. (BDSX) has a Quality factor score of 31/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Biodesix, Inc. a buy, hold, or sell?
MoatMap’s current signal for Biodesix, Inc. (BDSX) is Hold, based on a StockRank of 58/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Biodesix, Inc. in?
Biodesix, Inc. (BDSX) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).
Browse all ranked stocksBDSX deep dive reportAI ChampionsHow we score stocksSense-check another stock